Rapid HIV-AG/AT-IHA (rapid test)

Main article: HIV and AIDS

2024: Obtaining a marketing authorization

Resident Company Rapid BioSkolkovo has received a registration certificate for an express test for early diagnosis. virus human immunodeficiency (HIV) It makes it possible to identify the fact of infection for 10-12 days, the testing time is only eight minutes. The inclusion State of the rapid test in the register of medical devices allows the company to begin its production and sales. The Skolkovo Foundation announced this on March 4, 2024.

This development combines various diagnostic methods, providing an earlier and accurate detection of human immunodeficiency virus type 1 and 2. Compared to previous generations of tests, the fourth generation RAPID-HIV-AG/AT-IHA simultaneously detects the p24 antigen and antibodies to the virus, which makes it possible to determine the presence of HIV at the stored stages.

Despite the fact that Rapid Bio was founded only 4 years ago, the team has extensive experience in the development and implementation of affordable and accurate express diagnostics on the medical market. Russia For example, rapid tests for the determination of SARS-COV-2 antigen due to high quality quickly competed with similar domestic and imported products and are actively used in the Russian system. health care Early detection of such a socially significant disease as HIV provides an opportunity for managed control of the patient's status, which will maintain the quality of life at the proper level, said Kamil Zarubin, vice president, executive director of the Skolkovo Foundation's biomedical technology cluster.

Rapid Bio aims to expand the availability of 4th generation rapid HIV tests for medical facilities and clinical diagnostic laboratories. The company's capacity allows the production of 15 million tests per month. This volume of production can fully meet Russia's needs for rapid diagnosis of HIV and provide wide access to high-quality and effective diagnostic methods to combat the disease.

It is important to note that the test is Russian, with a full development and production cycle at the sites of the Skolkovo Innovation Center. The test is distinguished not only by its high specificity and sensitivity, one of its main features is the speed and simplicity of research, which does not require laboratory equipment and the creation of special conditions. The test results are ready in 8 minutes. All these factors make it an ideal tool in conditions of limited access to laboratory equipment, for example, during screening studies, medical examinations, NGO shares, in an outpatient clinic, - commented the general director of Rapid Bio, Angey Zhimbiev.